Postnatal changes in β‐adrenoceptors in the lung and the effect of hypoxia induced pulmonary hypertension of the newborn — Alison A. Hislop (2002) | RDL Network
Postnatal changes in β‐adrenoceptors in the lung and the effect of hypoxia induced pulmonary hypertension of the newborn
Article 2002 en
Authors
AH
Alison A. Hislop
JM
Jcw Mak
DK
David A. Kelly
Abstract
1 min read
β‐adrenoceptor activation leads to pulmonary vasodilatation. The increase in circulating catecholamines at birth may assist the postnatal fall in vascular resistance by their activation. To study β 1 ‐ and β 2 ‐adrenoceptors during postnatal adaptation, we used [ 125 I]‐iodocyanopindolol (ICYP) binding to lung membranes and sections to quantify and locate the binding sites in piglets from birth to 14 days of age and compared them with those in adult pigs. In addition, pulmonary hypertension was induced in newborn piglets by hypobaric hypoxia. In lung membranes the equilibrium dissociation constant ( K d ) did not change with age for total β‐adrenoceptors or for β 2 ‐adrenoceptors, but there was a significant increase in maximum binding sites (B max ) between birth and 3 days of age. On tissue sections, B max increased between 3 days and adulthood with no change in K d . Binding sites of β 1 ‐ and β 2 ‐adrenoceptors were localized to the bronchial epithelium, to endothelium of extra‐ and intra‐pulmonary arteries and to lung parenchyma. Total β‐adrenoceptor density increased with age at all locations ( P <0.05 – 0.01). At birth intrapulmonary arteries showed no binding, β 2 ‐adrenoceptors appeared on day 1 and increased up to 14 days of age. β 1 ‐adrenoceptors appeared by 3 days of age and increased with age. Hypobaric hypoxia from birth led to attenuation in the normal postnatal increase in receptor number, but hypoxia from 3 – 6 days did not decrease receptor density. The normal postnatal increase in β‐adrenoceptors suggests a potential for catecholamine induced dilatation in the lung during adaptation which is attenuated in pulmonary hypertension. British Journal of Pharmacology (2002) 135 , 1415–1424; doi: 10.1038/sj.bjp.0704597
Discussion(0)
No comments yet. Be the first to comment.